8 AI Drug Discovery and Manufacturing Stocks to Buy
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Novo Nordisk defends disappointing next-gen obesity drug: ‘It will be an important product'
Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.
Health Affairs4d
Pharmaceutical Tariffs: Potential Impacts And The Need For Vulnerability Assessments
The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful ...
Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...
BenefitsPRO6d
New allergy drug uses $25 copay coupons to drive early sales
The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...
Exclusive: FDA staff struggle to meet product review deadlines after DOGE layoffs
Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...
The Manila Times6d
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS' Saint-Beauzire site ...
Tribune Online on MSN1d
Expert to FG: Remove import duty, other levy on critical pharmaceutical products
An indigenous pharmaceutical company, St. Racheal’s Pharma has called on President Bola Tinubu to remove import duty and levy on critical pharmaceutical products.The company stated this is imperative ...